| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| iSpecimen Inc. | Director | Option | 168 | $860 | $5.12 | 25 Sep 2024 | Direct |
| Virpax Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 2,500 | 05 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ISPC | iSpecimen Inc. | 25 Sep 2024 | 1 | +$860 | 4 | Director | 27 Sep 2024, 19:19 |
| ISPC | iSpecimen Inc. | 25 Sep 2024 | 0 | $0 | 3 | Director | 27 Sep 2024, 19:15 |
| VRPX | Virpax Pharmaceuticals, Inc. | 05 Jul 2024 | 1 | $0 | 4 | Director | 10 Jul 2024, 16:10 |
| VRPX | Virpax Pharmaceuticals, Inc. | 05 Jul 2024 | 0 | $0 | 3 | Director | 10 Jul 2024, 16:09 |